XBIOTECH INC. Deferred Offering Costs
XBIOTECH INC. (XBIT) had Deferred Offering Costs of $1.04 million as of 2015-03-31, per its 10-Q filed 2015-06-18.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2016-04-15
- 2015-03-31: Deferred Offering Costs $1.04M.
- 2014-12-31: Deferred Offering Costs $324.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2015-03-31 | $1.04M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $324.00K 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |